Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Brodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis
Philip J. Mease, Mark C. Genovese, Maria Greenwald, et al.
New England Journal of Medicine (2014) Vol. 370, Iss. 24, pp. 2295-2306
Open Access | Times Cited: 376

Showing 26-50 of 376 citing articles:

Psoriatic arthritis
Oliver FitzGerald, Alexis Ogdie, Vinod Chandran, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 192
Therapeutic Targeting of IL-17 and IL-23 Cytokines in Immune-Mediated Diseases
G. Fragoulis, Stefan Siebert, Iain B. McInnes
Annual Review of Medicine (2015) Vol. 67, Iss. 1, pp. 337-353
Closed Access | Times Cited: 186
Role of the IL-23/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints
Marie‐Astrid Boutet, Alessandra Nerviani, Gabriele Gallo Afflitto, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 2, pp. 530-530
Open Access | Times Cited: 182
Autoimmune Renal Disease Is Exacerbated by S1P-Receptor-1-Dependent Intestinal Th17 Cell Migration to the Kidney
Christian F. Krebs, Hans‐Joachim Paust, Sonja Krohn, et al.
Immunity (2016) Vol. 45, Iss. 5, pp. 1078-1092
Open Access | Times Cited: 180
Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison
Joy Feld, Vinod Chandran, Nigil Haroon, et al.
Nature Reviews Rheumatology (2018) Vol. 14, Iss. 6, pp. 363-371
Closed Access | Times Cited: 179
Efficacy and safety of ixekizumab treatment for Japanese patients with moderate to severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis: Results from a 52‐week, open‐label, phase 3 study (UNCOVER‐J)
Hidehisa Saeki, Hidemi Nakagawa, Ko Nakajo, et al.
The Journal of Dermatology (2016) Vol. 44, Iss. 4, pp. 355-362
Open Access | Times Cited: 177
Role of inflammation, immunity, and oxidative stress in hypertension: New insights and potential therapeutic targets
Zenglei Zhang, Lin Zhao, Xingyu Zhou, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 160
Signaling pathways and targeted therapies for psoriasis
Jia Guo, H. Zhang, Wenrui Lin, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 127
Therapies for peripheral joint disease in psoriatic arthritis. A systematic review.
María Laura Acosta Felquer, Laura C. Coates, Enrique R. Soriano, et al.
The Journal of Rheumatology (2006) Vol. 33, Iss. 7, pp. 1422-30
Open Access | Times Cited: 184
Inhibition of interleukin-17, interleukin-23 and the TH17 cell pathway in the treatment of psoriatic arthritis and psoriasis
Philip J. Mease
Current Opinion in Rheumatology (2015) Vol. 27, Iss. 2, pp. 127-133
Closed Access | Times Cited: 166
Role of Inflammation and Immunity in Hypertension: Recent Epidemiological, Laboratory, and Clinical Evidence
Antoine Caillon, Ernesto L. Schiffrin
Current Hypertension Reports (2016) Vol. 18, Iss. 3
Closed Access | Times Cited: 165
Novel therapeutic targets in rheumatoid arthritis
Marije I. Koenders, Wim B. van den Berg
Trends in Pharmacological Sciences (2015) Vol. 36, Iss. 4, pp. 189-195
Closed Access | Times Cited: 149
Efficacy and safety of brodalumab in patients with generalized pustular psoriasis and psoriatic erythroderma: results from a 52-week, open-label study
Kenshi Yamasaki, Hidemi Nakagawa, Yoshiaki Kubo, et al.
British Journal of Dermatology (2016) Vol. 176, Iss. 3, pp. 741-751
Open Access | Times Cited: 144
Brodalumab for the Treatment of Psoriasis: A Review of Phase III Trials
Benjamin Farahnik, Kourosh Beroukhim, Michael Abrouk, et al.
Dermatology and Therapy (2016) Vol. 6, Iss. 2, pp. 111-124
Open Access | Times Cited: 134
Cartilage and Bone Destruction in Arthritis: Pathogenesis and Treatment Strategy: A Literature Review
Daisuke Tateiwa, Hideki Yoshikawa, Takashi Kaito
Cells (2019) Vol. 8, Iss. 8, pp. 818-818
Open Access | Times Cited: 131
A randomised phase II study evaluating the efficacy and safety of subcutaneously administered ustekinumab and guselkumab in patients with active rheumatoid arthritis despite treatment with methotrexate
Josef S Smolen, Sandeep K. Agarwal, Е. П. Иливанова, et al.
Annals of the Rheumatic Diseases (2017) Vol. 76, Iss. 5, pp. 831-839
Open Access | Times Cited: 129
Brodalumab, a human anti-interleukin-17-receptor antibody in the treatment of Japanese patients with moderate-to-severe plaque psoriasis: Efficacy and safety results from a phase II randomized controlled study
Hidemi Nakagawa, Hiroaki Niiro, Kenji Ootaki
Journal of Dermatological Science (2015) Vol. 81, Iss. 1, pp. 44-52
Closed Access | Times Cited: 127
IL-17 in the immunopathogenesis of spondyloarthritis
Leonie S. Taams, Kathryn J. A. Steel, Ushani Srenathan, et al.
Nature Reviews Rheumatology (2018) Vol. 14, Iss. 8, pp. 453-466
Open Access | Times Cited: 127
Clinical management of psoriatic arthritis
Filip Van den Bosch, Laura C. Coates
The Lancet (2018) Vol. 391, Iss. 10136, pp. 2285-2294
Open Access | Times Cited: 120
Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies
Joshua S. Davis, David Ferreira, Emma Paige, et al.
Clinical Microbiology Reviews (2020) Vol. 33, Iss. 3
Open Access | Times Cited: 118
The role of the Th17 cytokines IL-17 and IL-22 in Rheumatoid Arthritis pathogenesis and developments in cytokine immunotherapy
Debbie Roeleveld, Marije I. Koenders
Cytokine (2014) Vol. 74, Iss. 1, pp. 101-107
Closed Access | Times Cited: 116
Dactylitis: A hallmark of psoriatic arthritis
Gurjit S. Kaeley, Lihi Eder, Sibel Zehra Aydın, et al.
Seminars in Arthritis and Rheumatism (2018) Vol. 48, Iss. 2, pp. 263-273
Open Access | Times Cited: 113
Alteration of the intestinal microbiome characterizes preclinical inflammatory arthritis in mice and its modulation attenuates established arthritis
Rebecca Rogier, Heather Evans‐Marin, Julia Manasson, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 112
T Helper Cell Subsets in Clinical Manifestations of Psoriasis
Marco Diani, G. F. Altomare, Eva Reali
Journal of Immunology Research (2016) Vol. 2016, pp. 1-7
Open Access | Times Cited: 110
Management of psoriatic arthritis: Early diagnosis, monitoring of disease severity and cutting edge therapies
S. P. Raychaudhuri, Reason Wilken, Andrea Sukhov, et al.
Journal of Autoimmunity (2016) Vol. 76, pp. 21-37
Closed Access | Times Cited: 110

Scroll to top